<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fchem.2020.00772</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Preliminary Study on Novel Expedient Synthesis of 5-Azaisocoumarins by Transition Metal-Catalyzed Cycloisomerization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Yoon</surname> <given-names>Jeong A</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lim</surname> <given-names>Changjin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1002321/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Han</surname> <given-names>Young Taek</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/891212/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>College of Pharmacy, Dankook University</institution>, <addr-line>Cheonan-si</addr-line>, <country>South Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Pharmacy, Jeonbuk National University</institution>, <addr-line>Jeonju-si</addr-line>, <country>South Korea</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jiyong Hong, Duke University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Xiao-Wei Liang, Duke University, United States; Jongkook Lee, Kangwon National University, South Korea</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Changjin Lim <email>limcj&#x00040;jbnu.ac.kr</email></corresp>
<corresp id="c002">Young Taek Han <email>hanyt&#x00040;dankook.ac.kr</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Organic Chemistry, a section of the journal Frontiers in Chemistry</p></fn></author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>8</volume>
<elocation-id>772</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>06</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>07</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 Yoon, Lim and Han.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Yoon, Lim and Han</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>A preliminary study to develop a novel synthetic method for 3-aryl-5-azaisocoumarins was performed herein. The cycloisomerization of <italic>N</italic>-pyranonyl propargylamines in the AgOTf-catalyzed system efficiently afforded the desired 3-aryl-5-azaisocoumarins in a highly regioselective manner. This unprecedented method is expected as an expedient alternative synthetic route to 5-azaisocoumarins because the regioselectivity problem is circumvented, and it is easier to introduce substituents on the pyridine ring compared to previously reported intramolecular lactonization approaches.</p></abstract>
<kwd-group>
<kwd>5-azaisocoumarin</kwd>
<kwd>cycloisomerization</kwd>
<kwd>synthetic method</kwd>
<kwd>AgOTf</kwd>
<kwd><italic>N</italic>-pyranonyl propargylamine</kwd>
<kwd>Ag(I)-catalysis</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Research Foundation of Korea<named-content content-type="fundref-id">10.13039/501100003725</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="40"/>
<page-count count="9"/>
<word-count count="5973"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Isocoumarins, including 3,4-dihydroisocoumarin, are naturally abundant flavonoid scaffolds, that exhibit diverse pharmacological activities (Saeed, <xref ref-type="bibr" rid="B30">2016</xref>; Saddiqa et al., <xref ref-type="bibr" rid="B28">2017</xref>). In particular, 3-aryl isocoumarins possess unique and potent biological functions including antifungal (Saeed, <xref ref-type="bibr" rid="B29">2003</xref>), anti-diabetic (Kim et al., <xref ref-type="bibr" rid="B14">2017</xref>), immunomodulatory (Matsuda et al., <xref ref-type="bibr" rid="B20">1998</xref>), antiallergic (Yoshikawa et al., <xref ref-type="bibr" rid="B40">1992</xref>, <xref ref-type="bibr" rid="B38">1994</xref>, <xref ref-type="bibr" rid="B39">1996</xref>), and antimicrobial (Yoshikawa et al., <xref ref-type="bibr" rid="B40">1992</xref>, <xref ref-type="bibr" rid="B38">1994</xref>, <xref ref-type="bibr" rid="B39">1996</xref>) activities, attracting the attention of synthetic and medicinal chemists. In medicinal chemistry, pyridine is considered to be the most efficient and popular bioisosteres with a phenyl moiety to improve biological activities and PK/PD profiles (Foye, <xref ref-type="bibr" rid="B8">2008</xref>; Gaikwad et al., <xref ref-type="bibr" rid="B9">2012</xref>). In this regard, azaisocoumarins, including 3-aryl-5-azaisocoumarin, are potential privileged scaffolds for developing drug candidates to treat a diverse range of diseases. Hence, there has been significant interest in the development of an efficient and novel synthetic route to 3-aryl-5-azaisocoumarin.</p>
<p>Despite the continual development of synthetic strategies for 3-aryl-isocoumarin analogs because of their interesting biological activities (Pal et al., <xref ref-type="bibr" rid="B24">2011</xref>; Saddiqa et al., <xref ref-type="bibr" rid="B28">2017</xref>), only a few methods and examples have been reported for the synthesis of 3-aryl-5-azaisocoumarin (Hellal et al., <xref ref-type="bibr" rid="B12">2008</xref>; Li et al., <xref ref-type="bibr" rid="B15">2010</xref>; Begouin and Maria-Jo&#x000E3;o, <xref ref-type="bibr" rid="B3">2011</xref>; Panda et al., <xref ref-type="bibr" rid="B25">2011</xref>; Park et al., <xref ref-type="bibr" rid="B26">2011</xref>; Singh et al., <xref ref-type="bibr" rid="B33">2018</xref>). To date, the synthesis of 3-aryl-5-azaisocoumarins has mostly been accomplished in the same manner as that of 3-aryl-isocoumarins, i.e., via construction of the 2-pyrone moiety in the final step via the intramolecular lactonization of 2-alkylnyl nicotinate derivatives. Because lactonization between the activated alkyne and <italic>ortho</italic>-carboxylate can occur by the 6-<italic>endo</italic>-dig or 5-<italic>exo</italic>-dig cyclization sequence (pathways a and b, respectively, in <xref ref-type="fig" rid="F1">Figure 1</xref>), selectivity against methylenefuranone skeleton is a major challenge in these 2-pyrone formation routes. For instance, Li et al. reported the synthesis of 3-aryl-5-azaisocoumarin the Pinnick-type oxidative lactonization of 2-(phenylethynyl)-nicotinaldehyde in 2010 (<xref ref-type="fig" rid="F1">Figure 1a</xref>) (Li et al., <xref ref-type="bibr" rid="B15">2010</xref>). The transition metal-mediated intramolecular lactonizations of 2-alkynyl nicotinates or 2-alkynyl nicotinaldehyde are popular approaches to obtain 5-azaisocoumarins by construction of the 2-pyrone moiety. Queiroz et al. attempted to make the 2-pyrone moiety of 3-aryl-5-azaisocoumarin via the one-pot Sonogashira coupling/transition metal catalyzed alkyne activation cascade (<xref ref-type="fig" rid="F1">Figure 1b</xref>) (Begouin and Maria-Jo&#x000E3;o, <xref ref-type="bibr" rid="B3">2011</xref>). These two methods produced 5-<italic>exo</italic>-cyclized furanone as a major product. Youn et al. adopted NHC-catalyzed alkyne activation for the synthesis of 5-azaisocoumarins, which selectively afforded a 6-<italic>endo</italic> or 5-<italic>exo</italic> cyclized product with appropriate reaction conditions (<xref ref-type="fig" rid="F1">Figure 1c</xref>) (Park et al., <xref ref-type="bibr" rid="B26">2011</xref>). 3-Butyl-5-azaisocoumarin was selectively synthesized via 6-<italic>endo</italic> cyclization mode from the corresponding precursor. However, for the arylethynyl precursor, the major product was the 5-<italic>exo</italic>-cyclized lactone instead of 3-aryl-5-azaisocoumarin. Several successful examples of 3-aryl-5-azaisocoumarin synthesis via selective formation of the 2-pyrone moiety have been reported. The Bihel (<xref ref-type="fig" rid="F1">Figure 1d</xref>) (Hellal et al., <xref ref-type="bibr" rid="B12">2008</xref>) and Sarkar groups (<xref ref-type="fig" rid="F1">Figure 1e</xref>) (Panda et al., <xref ref-type="bibr" rid="B25">2011</xref>) reported 3-aryl-5-azaisocoumarin synthesis by transition metal-catalyzed 6-<italic>endo</italic>-lactonization from ethynylnicotinate or ethynylnicotinaldehyde precursors, respectively. In addition, selective 6-<italic>endo</italic>-lactonization toward pyrano[4,3-<italic>b</italic>]quinolin-1-one, a phenyl-fused azaisocoumarin, was accomplished under metal/additive-free domino reaction conditions (<xref ref-type="fig" rid="F1">Figure 1f</xref>) (Singh et al., <xref ref-type="bibr" rid="B33">2018</xref>). In addition to the selectivity problem, previous 2-pyrone formation approaches are inefficient for the installation of substituents on pyridine moiety of 5-azaisocoumarins.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Approaches for the synthesis of 5-azaisocoumarins. <bold>(a)</bold> Li&#x00027;s synthesis of 5-azaisocoumarins; <bold>(b)</bold> Queiroz&#x00027;s synthesis of 5-azaisocoumarins; <bold>(c)</bold> Youn&#x00027;s synthesis of 5-azaisocoumarins; <bold>(d)</bold> Bihel&#x00027;s synthesis of 5-azaisocoumarins; <bold>(e)</bold> Sarkar&#x00027;s synthesis of 5-azaisocoumarins; <bold>(f)</bold> Singh&#x00027;s synthesis of 5-azaisocoumarins.</p></caption>
<graphic xlink:href="fchem-08-00772-g0001.tif"/>
</fig>
<p>Recently, the metal-catalyzed 6-<italic>endo</italic>-dig cycloisomerization of <italic>N</italic>-propargyl enaminone derivatives has been widely used for the synthesis of pyridine-fused complex heterocycles, including azaanthraquinone, and steroidal pyridine (Abbiati et al., <xref ref-type="bibr" rid="B1">2003</xref>; Yan et al., <xref ref-type="bibr" rid="B36">2007</xref>; Jiang et al., <xref ref-type="bibr" rid="B13">2010</xref>; Fei et al., <xref ref-type="bibr" rid="B7">2011</xref>). In addition, intensive efforts to establish efficient synthetic methods for pyridine-fused coumarins and natural products using the metal-catalyzed cycloisomerization of <italic>N</italic>-propargyl enaminone intermediates have been reported (Ahn et al., <xref ref-type="bibr" rid="B2">2019</xref>; Yoon and Han, <xref ref-type="bibr" rid="B37">2019</xref>). In these studies, the pyridine moiety was constructed in a highly 6-<italic>endo</italic>-selective manner, which can be explained by &#x003C3;-bond formation between the nucleophilic enolizable &#x003B1;-position and exo-position of the electrophilic alkyne-metal complex and subsequent spontaneous oxidation to form a stable aromatic pyridine ring (Abbiati et al., <xref ref-type="bibr" rid="B1">2003</xref>; Yan et al., <xref ref-type="bibr" rid="B36">2007</xref>; Cacchi et al., <xref ref-type="bibr" rid="B4">2008</xref>; Jiang et al., <xref ref-type="bibr" rid="B13">2010</xref>; Fei et al., <xref ref-type="bibr" rid="B7">2011</xref>; Miku&#x00161;ek et al., <xref ref-type="bibr" rid="B21">2016</xref>; Lyubov&#x00027;N et al., <xref ref-type="bibr" rid="B17">2018</xref>; Ahn et al., <xref ref-type="bibr" rid="B2">2019</xref>). It was anticipated that construction of the pyridine moiety via cycloisomerization of <italic>N</italic>-propargylamine intermediates in the last-stage would be an efficient strategy for the synthesis of 3-aryl-5-azaisocoumarins. As part of our effort to develop a novel synthetic approach toward privileged 3-aryl-5-azaisocoumarin scaffolds, we investigated the metal-catalyzed cycloisomerization of <italic>N</italic>-pyranonyl propargylamines.</p>
<p>Herein, we describe a concise synthesis of 3-aryl-5-azaisocoumarins via AgOTf-catalyzed cycloisomerization, which to the best of our knowledge, has not been reported to date.</p></sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>General Information</title>
<p>Unless noted otherwise, all starting materials and reagents were obtained commercially and were used without further purification. All solvents utilized for routine product isolation and chromatography were of reagent grade and glass-distilled, and reaction flasks were dried at 100&#x000B0;C before use. Flash column chromatography was performed using silica gel 60 (230&#x02013;400 mesh, Merck, Kenilworth, NJ, USA) with the indicated solvents. Thin-layer chromatography (TLC) was performed using 0.25-mm silica gel plates (Merck, Kenilworth, NJ, USA). Mass spectra were obtained using an Agilent 6530 Q-TOF (Santa Clara, CA, USA) instrument. Infrared spectra were recorded on a JASCO FT-IR-4200 spectrometer (Tokyo, Japan). <sup>1</sup>H and <sup>13</sup>C spectra were recorded on a Brucker Analytik ADVANCE digital 500 (500 MHz) (Billerica, MA, USA) and BRUKER AVANCE-800 (Billerica, MA, USA). Chemical shifts are expressed in parts per million (ppm, &#x003B4;) downfield from tetramethylsilane and are referenced to the deuterated solvent. <sup>1</sup>HNMR data are reported in the order of chemical shift, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; bs, broad singlet; and/or multiple resonances), number of protons, and coupling constant in hertz (Hz).</p>
<sec>
<title>2-Oxo-6-phenyl-2H-pyran-4-yl 4-methylbenzenesulfonate (2)</title>
<p>To a stirred solution of <bold>1</bold> (500 mg, 2.66 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) were added tosyl chloride (507 mg, 2.66 mmol) and Et<sub>3</sub>N (1.11 mL, 7.98 mmol) at ambient temperature. After stirring for 3 h, the reaction mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated <italic>in vacuo</italic>. The residue was purified by flash column chromatography (EtOAc/<italic>n</italic>-Hexane = 1: 5) to give 838 mg (92%) of <bold>2</bold> as a yellow solid.</p>
<p>m.p.: 128&#x02013;130&#x000B0;C; R<sub>f</sub> = 0.67 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) &#x003B4; 7.86 (d, 2H, <italic>J</italic> = 8.3 Hz, Ar-H), 7.78 (d, 2H, <italic>J</italic> = 6.9 Hz, Ar-H), 7.51&#x02013;7.45 (m, 3H, Ar-H), 7.40 (d, 2H, <italic>J</italic> = 8.0 Hz, Ar-H), 6.61 (d, 1H<italic>, J</italic> = 1.8 Hz, vinyl H), 5.91 (d, 1H, <italic>J</italic> = 1.8 Hz, cyclic-CH), 2.48 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>) &#x003B4; 162.4, 162.3, 162.2, 146.9, 131.9, 131.8, 130.5, 130.5, 129.2, 128.6, 126.0, 101.7, 98.3, 22.0; IR (thin film, neat) &#x003BD;<sub>max</sub> 1,736, 1,631, 1,556, 1,496, 1,386, 1,198, 1,139, 1,091, 916, 748 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 343 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>18</sub>H<sub>15</sub>O<sub>5</sub>S (M &#x0002B; H<sup>&#x0002B;</sup>) 343.0635; found 343.0631.</p></sec></sec>
<sec>
<title>General Procedure I for Nucleophilic Aromatic Substitution</title>
<p>To a stirred solution of <bold>2</bold> (1 equiv.) and <italic>N,N</italic>-diisopropylethylamine (3 equiv.) in MeCN (0.1 M solution) was added propargylamine hydrochloride (1.5 equiv.) at ambient temperature. After stirring for 14 h at 80&#x000B0;C, the reaction mixture was quenched with 1<italic>N</italic> HCl and extracted with EtOAc. The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated <italic>in vacuo</italic>. The residue was purified by flash column chromatography (EtOAc/<italic>n</italic>-Hexane = 1: 1) to give title compounds (<bold>3a</bold>&#x02013;<bold>3i</bold>).</p>
<sec>
<title>6-Phenyl-4-(prop-2-yn-1-ylamino)-3,4-dihydro-2H-pyran-2-one (3a)</title>
<p>Yellow solid of <bold>3a</bold> (1.13 g, 69%) was obtained via General Procedure I from 2.50 g of <bold>2</bold>.</p>
<p>m.p.: 169&#x02013;171&#x000B0;C; R<sub>f</sub> = 0.29 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.72 (s, 3H, Ar-H), 7.54&#x02013;7.51 (m, 2H, Ar-H), 6.55 (s, 1H, vinyl H), 5.03 (d, 1H, <italic>J</italic> = 1.3 Hz, vinyl H), 4.01 (s, 2H, CH<sub>2</sub>), 3.30 (t, 1H, <italic>J</italic> = 2.3 Hz, CH); <sup>13</sup>C-NMR (125 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 157.8, 157.1, 131.6, 130.6, 129.1, 125.1, 97.0, 80.7, 79.5, 74.6, 31.3; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,289, 3,089, 1,666, 1,549, 1,298, 1,198, 1,063, 847, 767, 691 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 226 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>14</sub>H<sub>12</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 226.0863; found 226.0856.</p></sec>
<sec>
<title>4-(But-2-yn-1-ylamino)-6-phenyl-3,4-dihydro-2H-pyran-2-one (3b)</title>
<p>Yellow solid of <bold>3b</bold> (25 mg, 72%) was obtained via General Procedure I from 50 mg of <bold>2</bold>.</p>
<p>m.p.: 181&#x02013;183&#x000B0;C; R<sub>f</sub> = 0.38 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.72 (s, 2H, Ar-H), 7.68 (t, 1H, <italic>J</italic> = 5.3 Hz, NH), 7.54&#x02013;7.49 (m, 3H, Ar-H), 6.54 (s, 1H, vinyl H), 4.99 (s, 1H, vinyl H), 3.94 (s, 2H, CH<sub>2</sub>), 1.81 (t, 3H, <italic>J</italic> = 2.1 Hz, CH<sub>3</sub>); <sup>13</sup>C-NMR (125 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 157.7, 157.2, 131.6, 130.5, 129.1, 125.1, 97.0, 80.4, 79.6, 74.6, 31.6, 3.0; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,269, 3,090, 1,658, 1,547, 1,298, 1,194, 1,063, 992, 850, 768, 692 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 240 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 240.1019; found 240.1018.</p></sec>
<sec>
<title>4-(But-3-yn-2-ylamino)-6-phenyl-3,4-dihydro-2H-pyran-2-one (3c)</title>
<p>Yellow solid of <bold>3c</bold> (17 mg, 48%) was obtained via General Procedure I from 50 mg of <bold>2</bold>.</p>
<p>m.p.: 190&#x02013;191&#x000B0;C; R<sub>f</sub> = 0.30 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.72 (s, 2H, Ar-H), 7.66 (d, 1H, <italic>J</italic> = 6.9 Hz, NH), 7.54&#x02013;7.50 (m, 3H, Ar-H), 6.53 (s, 1H, vinyl H), 5.06 (d, 1H, <italic>J</italic> = 1.5 Hz, vinyl H), 4.37 (s, 1H, CH), 3.32 (d, 1H, <italic>J</italic> = 2.1 Hz, CH), 1.43 (d, 3H<italic>, J</italic> = 6.8 Hz, CH<sub>3</sub>); <sup>13</sup>C-NMR (125 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 156.9, 156.4, 131.6, 130.5, 129.1, 126.9, 125.1, 97.0, 83.8, 81.0, 73.5, 20.9; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,283, 3,066, 1,667, 1,550, 1,298, 1,198, 1,176, 1,063, 847, 758, 691 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 240 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 240.1019; found 240.1029.</p></sec>
<sec>
<title>6-Phenyl-4-((3-phenylprop-2-yn-1-yl)amino)-3,4-dihydro-2H-pyran-2-one (3d)</title>
<p>Yellow solid of <bold>3d</bold> (24 mg, 52%) was obtained via General Procedure I from 50 mg of <bold>2</bold>.</p>
<p>m.p.: 194&#x02013;196&#x000B0;C; R<sub>f</sub> = 0.24 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, DMSO-d<sub>6</sub>), &#x003B4; 7.83 (t, 1H, <italic>J</italic> = 5.3 Hz, Ar-H), 7.74 (s, 1H, Ar-H), 7.54&#x02013;7.51 (m, 3H, Ar-H), 7.45&#x02013;7.38 (m, 5H, Ar-H), 6.59 (d, 1H, <italic>J</italic> = 6.6 Hz, vinyl H), 5.12 (d, 1H, <italic>J</italic> = 1.3 Hz, vinyl H), 4.28 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C-NMR (125 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 157.9, 157.2, 131.6, 131.4, 130.6, 129.1, 128.8, 128.7, 125.1, 121.9, 97.1, 85.4, 83.1, 80.7, 32.1; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,271, 3,089, 1,663, 1,544, 1,451, 1,293, 1,199, 1,072, 849, 768, 691 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 324 (M &#x0002B; Na<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>20</sub>H<sub>15</sub>NNaO<sub>2</sub> (M &#x0002B; Na<sup>&#x0002B;</sup>) 324.0995; found 324.0990.</p></sec>
<sec>
<title>6-phenyl-4-((3-(o-tolyl)prop-2-yn-1-yl)amino)-2H-pyran-2-one (3e)</title>
<p>Yellow solid of <bold>3e</bold> (69 mg, 75%) was obtained via General Procedure I from 100 mg of <bold>2</bold>.</p>
<p>m.p.: 163&#x02013;164&#x000B0;C; R<sub>f</sub> = 0.40 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.84 (s, 1H, NH), 7.74 (s, 2H, Ar-H), 7.55&#x02013;7.48 (m, 3H, Ar-H), 7.38 (d, <italic>J</italic> = 7.6 Hz, 1H, Ar-H), 7.30&#x02013;7.23 (m, 2H, Ar-H), 7.22 &#x02013; 7.12 (m, 1H, Ar-H), 6.59 (s, 1H, vinyl H), 5.15 (d, <italic>J</italic> = 1.2 Hz, 1H, vinyl H), 4.31 (s, 2H, CH<sub>2</sub>), 2.36 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C-NMR (200 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 157.8, 157.1, 139.7, 131.6, 131.6, 130.6, 129.6, 129.1, 128.7, 125.9, 125.1, 121.8, 97.1, 89.2, 82.0, 80.9, 32.2, 20.2; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,263, 3,072, 1,664, 1,544, 1,289, 1,182, 1,027, 759, 689 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 316 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>21</sub>H<sub>18</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 316.1332; found 316.1333.</p></sec>
<sec>
<title>4-(hex-5-en-2-yn-1-ylamino)-6-phenyl-2H-pyran-2-one (3g)</title>
<p>Yellow solid of <bold>3g</bold> (53 mg, 68%) was obtained via General Procedure I from 100 mg of <bold>2</bold>.</p>
<p>m.p.: 119&#x02013;120&#x000B0;C; R<sub>f</sub> = 0.39 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.82&#x02013;7.65 (m, 3H, Ar-H &#x00026; NH), 7.54&#x02013;7.48 (m, 3H, Ar-H), 6.55 (s, 1H, vinyl H), 5.87&#x02013;5.69 (ddt, <italic>J</italic> = 17.0, 10.1, 5.2 Hz, 1H, vinyl H), 5.30 (dd, <italic>J</italic> = 17.0, 1.7 Hz, 1H, vinyl H), 5.10 (d, <italic>J</italic> = 9.7 Hz, 1H, vinyl H), 5.03 (d, <italic>J</italic> = 1.5 Hz, 1H, vinyl H), 4.02 (s, 2H, CH<sub>2</sub>), 3.05&#x02013;3.01 (m, 2H, CH<sub>2</sub>); <sup>13</sup>C-NMR (200 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.6, 157.7, 157.1, 132.8, 131.6, 130.6, 129.1, 125.1, 116.0, 97.0, 80.5, 80.3, 78.1, 31.7, 22.3; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,272, 3,092, 1,664, 1,548, 1,297, 1,182, 1,038, 918, 767, 691 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 266 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>17</sub>H<sub>16</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 266.1176; found 266.1169.</p></sec>
<sec>
<title>4-((3-(cyclohex-2-en-1-yl)prop-2-yn-1-yl)amino)-6-phenyl-2H-pyran-2-one (3h)</title>
<p>Yellow oil of <bold>3h</bold> (39 mg, 44%) was obtained via General Procedure I from 100 mg of <bold>2</bold>.</p>
<p>R<sub>f</sub> = 0.35 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.72 (s, 2H, Ar-H), 7.66 (s, 1H, NH), 7.54&#x02013;7.48 (m, 3H, Ar-H), 6.55 (s, 1H, vinyl H), 5.72&#x02013;5.68 (m, 1H, vinyl H), 5.58&#x02013;5.55 (m, 1H, vinyl H), 5.00 (s, 1H, vinyl H), 3.98 (s, 2H, CH<sub>2</sub>), 3.18&#x02013;3.11 (m, 1H, CH), 1.98&#x02013;1.91 (m, 2H, 2 &#x000D7; CH<sub>2</sub>), 1.85&#x02013;1.79 (m, 1H, 1/2 &#x000D7; CH<sub>2</sub>), 1.73&#x02013;1.67 (m, 1H, 1/2 &#x000D7; CH<sub>2</sub>), 1.60&#x02013;1.55 (m, 1H, 1/2 &#x000D7; CH<sub>2</sub>), 1.54&#x02013;1.48 (m, 1H, 1/2 &#x000D7; CH<sub>2</sub>); <sup>13</sup>C-NMR (200 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.5, 157.7, 157.1, 131.6, 130.5, 129.1, 127.8, 126.8, 125.1, 97.1, 86.4, 80.4, 75.3, 31.7, 28.9, 26.6, 24.1, 20.0; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,117, 2,887, 1,670, 1,564, 1,337, 1,245, 767, 688 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 306 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>20</sub>H<sub>20</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 306.1489; found 306.1486.</p></sec>
<sec>
<title>6-phenyl-4-((3-(triisopropylsilyl)prop-2-yn-1-yl)amino)-2H-pyran-2-one (3i)</title>
<p>Yellow solid of <bold>3i</bold> (80 mg, 72%) was obtained via General Procedure I from 100 mg of <bold>2</bold>.</p>
<p>m.p.: 175&#x02013;176&#x000B0;C; R<sub>f</sub> = 0.60 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, DMSO-d<sub>6</sub>) &#x003B4; 7.74 (s, 2H, Ar-H), 7.68 (s, 1H, NH), 7.54&#x02013;7.47 (m, 3H, Ar-H), 6.57 (s, 1H, vinyl H), 5.07 (d, <italic>J</italic> = 1.9 Hz, 1H, vinyl H), 4.09 (s, 2H, CH<sub>2</sub>), 1.05&#x02013;0.98 (m, 21H, TIPS-H); <sup>13</sup>C-NMR (200 MHz, DMSO-d<sub>6</sub>) &#x003B4; 162.4, 157.7, 157.0, 131.6, 130.5, 129.1, 125.1, 103.6, 97.0, 83.6, 81.1, 32.3, 18.4, 10.6; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,272, 3,075, 1,670, 1,549, 1,245, 1,182, 1,038, 883, 767, 677 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 382 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>23</sub>H<sub>32</sub>NO<sub>2</sub>Si (M &#x0002B; H<sup>&#x0002B;</sup>) 382.2197; found 382.2193.</p></sec></sec>
<sec>
<title>General Procedure II for AgOTf-Catalyzed Cycloisomerization</title>
<p>To a stirred solution of <bold>3a</bold>&#x02013;<bold>3f</bold> (1 equiv.) in DMSO (0.06 M) was added AgOTf (0.2 equiv.) at ambient temperature. After stirring for 2&#x02013;4 h at 120&#x000B0;C, the reaction mixture was cooled to ambient temperature, quenched with water and extracted with EtOAc. The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated <italic>in vacuo</italic>. The residue was purified by flash column chromatography (EtOAc/<italic>n</italic>-Hexane = 1: 3) to give title compounds (<bold>4a</bold>&#x02013;<bold>4f</bold>).</p>
<sec>
<title>7-Phenyl-5H-pyrano[4,3-b]pyridin-5-one (4a)</title>
<p>Yellow solid of <bold>4a</bold> (13 mg, 66%) was obtained via General Procedure II from 20 mg of <bold>3a</bold>.</p>
<p>m.p.: 135&#x02013;136&#x000B0;C; R<sub>f</sub> = 0.47 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, CDCl<sub>3</sub>) &#x003B4; 8.94 (dd, 1H, <italic>J</italic> = 1.8, 4.6 Hz, Ar-H), 8.55 (dd, 1H, <italic>J</italic> = 1.4, 7.8 Hz, Ar-H), 7.93&#x02013;7.91 (m, 2H, Ar-H), 7.51&#x02013;7.47 (m, 3H, Ar-H), 7.43 (dd, 1H, <italic>J</italic> = 4.6, 7.9 Hz, Ar-H), 7.23 (s, 1H, vinyl H); <sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>) &#x003B4; 162.1, 157.6, 156.3, 155.1, 137.9, 131.5, 131.0, 129.2, 125.9, 123.0, 117.2, 103.6; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,067, 1,735, 1,633, 1,561, 1,450, 1,216, 1,044, 1,035, 753, 688 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 224 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>14</sub>H<sub>10</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 224.0706; found 224.0707.</p></sec>
<sec>
<title>4-Methyl-7-phenyl-5H-pyrano[4,3-b]pyridin-5-one (4b)</title>
<p>Yellow solid of <bold>4b</bold> (16 mg, 65%) was obtained via General Procedure II from 25 mg of <bold>3b</bold>.</p>
<p>m.p.: 113&#x02013;114&#x000B0;C; R<sub>f</sub> = 0.58, (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) &#x003B4; 8.68 (d, 1H, <italic>J</italic> = 4.9 Hz, Ar-H), 7.93&#x02013;7.91 (m, 2H, Ar-H), 7.51&#x02013;7.47 (m, 3H, Ar-H), 7.21&#x02013;7.20 (m, 2H, Ar-H &#x00026; vinyl H), 2.86 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>) &#x003B4; 161.3, 157.1, 156.2, 154.6, 153.6, 131.4, 130.9, 129.1, 125.8, 125.7, 116.2, 103.8, 22.7; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,060, 1,734, 1,637, 1,574, 1,465, 1,228, 1,058, 1,034, 847, 762, 681 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 238 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>15</sub>H<sub>12</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 238.0863; found 238.0860.</p></sec>
<sec>
<title>2-Methyl-7-phenyl-5H-pyrano[4,3-b]pyridin-5-one (4c)</title>
<p>Yellow solid of <bold>4c</bold> (11 mg, 54%) was obtained via General Procedure II from 20 mg of <bold>3c</bold>.</p>
<p>m.p.: 129&#x02013;130&#x000B0;C; R<sub>f</sub> = 0.53 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) &#x003B4; 8.43 (d, 1H, <italic>J</italic> = 8.1 Hz, Ar-H), 7.93&#x02013;7.90 (m, 2H, Ar-H), 7.51&#x02013;7.47 (m, 3H, Ar-H), 7.30 (d, 1H, <italic>J</italic> = 8.1 Hz, Ar-H), 7.22 (s, 1H, vinyl H), 2.72 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>) &#x003B4; 166.6, 162.2, 157.6, 154.8, 137.8, 131.6, 130.9, 129.1, 125.8, 123.3, 114.7, 103.6, 25.5; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,061, 1,752, 1,630, 1,570, 1,460, 1,241, 1,119, 1,064, 1,030, 762, 687 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 238 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>15</sub>H<sub>12</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 238.0863; found 238.0857.</p></sec>
<sec>
<title>4,7-Diphenyl-5H-pyrano[4,3-b]pyridin-5-one (4d)</title>
<p>Yellow solid of <bold>4d</bold> (12 mg, 60%) was obtained via General Procedure II from 20 mg of <bold>3d</bold>.</p>
<p>m.p.: 142&#x02013;144&#x000B0;C; R<sub>f</sub> = 0.61 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) &#x003B4; 8.86 (d, 1H, <italic>J</italic> = 4.9 Hz, Ar-H), 7.94&#x02013;7.92 (m, 2H, Ar-H), 7.50&#x02013;7.48 (m, 6H, Ar-H), 7.40&#x02013;7.37 (m, 3H, Ar-H), 7.28 (d, 1H, <italic>J</italic> = 4.2 Hz, vinyl H); <sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>) &#x003B4; 160.1, 157.5, 156.4, 154.7, 154.6, 138.5, 131.3, 131.0, 129.1, 128.8, 128.3, 128.2, 125.8, 125.5, 114.3, 103.7; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,058, 1,745, 1,637, 1,568, 1,463, 1,222, 1,060, 1,029, 856, 764, 696 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 300 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>20</sub>H<sub>14</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 300.1019; found 300.1017.</p></sec>
<sec>
<title>7-phenyl-4-(o-tolyl)-5H-pyrano[4,3-b]pyridin-5-one (4e)</title>
<p>Yellow solid of <bold>4e</bold> (34 mg, 50%) was obtained via General Procedure II from 68 mg of <bold>3e</bold>.</p>
<p>m.p.: 137&#x02013;139&#x000B0;C; R<sub>f</sub> = 0.62 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, CDCl<sub>3</sub>) &#x003B4; 8.90 (s, 1H, Ar-H), 7.91&#x02013;7.88 (m, 2H, Ar-H), 7.49&#x02013;7.45 (m, 3H, Ar-H), 7.36&#x02013;7.32 (m, 2H, Ar-H), 7.30&#x02013;7.25 (m, 2H, Ar-H), 7.22&#x02013;7.18 (m, 1H, Ar-H), 7.06 (d, <italic>J</italic> = 6.9 Hz, 1H, vinyl H), 2.09 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C-NMR (200 MHz, CDCl<sub>3</sub>) &#x003B4; 159.7, 157.9, 156.0, 154.9, 154.4, 138.5, 134.7, 131.2, 131.1, 123.0, 129.2, 128.6, 127.3, 125.9, 125.8, 125.3, 115.5, 103.3, 20.0; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,066, 1,746, 1,636, 1,568, 1,495, 1,223, 1,027, 761, 688 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 314 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>21</sub>H<sub>16</sub>NO<sub>2</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 314.1176; found 314.1174.</p></sec>
<sec>
<title>4-(3-nitrophenyl)-7-phenyl-5H-pyrano[4,3-b]pyridin-5-one (4f)</title>
<p><italic>N</italic>-pyranonyl propargylamine <bold>3f</bold> was obtained via General Procedure I from 100 mg of <bold>2</bold>. The crude <bold>3f</bold> was used for the next step without further purification. Yellow solid of <bold>4f</bold> (32 mg, 32% for 2 steps) was obtained via General Procedure II from the crude <bold>3f</bold>.</p>
<p>m.p.: 261&#x02013;262&#x000B0;C; R<sub>f</sub> = 0.48 (EtOAc/<italic>n</italic>-Hexane = 1: 1); <sup>1</sup>H-NMR (800 MHz, DMSO-d<sub>6</sub>) &#x003B4; 9.02 (d, <italic>J</italic> = 4.8 Hz, 1H, Ar-H), 8.38 (t, <italic>J</italic> = 1.9 Hz, 1H, Ar-H), 8.32 (ddd, <italic>J</italic> = 8.3, 2.3, 0.9 Hz, 1H, Ar-H), 8.01 (dd, <italic>J</italic> = 8.1, 1.5 Hz, 2H, Ar-H), 7.95 (ddd, <italic>J</italic> = 7.6, 1.4, 1.1 Hz, 1H, Ar-H), 7.77 (t, <italic>J</italic> = 7.9 Hz, 1H, Ar-H), 7.60 (s, 1H, Ar-H), 7.58&#x02013;7.53 (m, 3H, Ar-H), 7.47 (d, <italic>J</italic> = 4.8 Hz, 1H, vinyl H); <sup>13</sup>C-NMR (200 MHz, DMSO-d<sub>6</sub>) &#x003B4; 159.9, 156.1, 155.8, 155.6, 149.9, 147.3, 140.2, 135.1, 130.9, 130.8, 129.4, 129.2, 125.4, 125.3, 123.5, 123.1, 114.0, 103.9; IR (thin film, neat) &#x003BD;<sub>max</sub> 3,115, 1,796, 1,637, 1,542, 1,446, 1,219, 1,038, 856, 759, 676 cm<sup>&#x02212;1</sup>; LR-MS (ESI&#x0002B;) <italic>m/z</italic> 345 (M &#x0002B; H<sup>&#x0002B;</sup>); HR-MS (ESI&#x0002B;) calcd for C<sub>20</sub>H<sub>13</sub>N<sub>2</sub>O<sub>4</sub> (M &#x0002B; H<sup>&#x0002B;</sup>) 345.0870; found 345.0867.</p>
</sec></sec></sec>
<sec id="s3">
<title>Results and Discussions</title>
<p>Our research on the development of a novel synthetic route toward 3-aryl-5-azaisocoumarin commenced with the preparation of cycloisomerization precursors. As shown in <xref ref-type="fig" rid="S1">Scheme 1</xref>, <italic>N</italic>-pyranonyl propargylamine precursors (<bold>3a</bold>&#x02013;<bold>3k</bold>) were prepared according to literature procedures with slight modifications (Dong et al., <xref ref-type="bibr" rid="B6">2011</xref>). The known hydroxy-2-pyrone <bold>1</bold> (Prasad et al., <xref ref-type="bibr" rid="B27">1995</xref>) was treated with tosyl chloride and triethylamine to afford tosylate <bold>2</bold> in 92% yield. Nucleophilic aromatic substitution of pyrone <bold>2</bold> with commercially available hydrochloride salts of propargylamine or diverse known substituted propargylamine (Experimental details: see <xref ref-type="supplementary-material" rid="SM1">Supplementary Materials</xref>) readily afforded the corresponding <italic>N</italic>-pyranonyl propargylamines <bold>3a</bold>&#x02013;<bold>3h</bold> in moderate yields (48&#x02013;74%). However, 3-bromopropargyl- and 1-phenylpropargyl analogs (<bold>3j</bold>&#x02013;<bold>3k</bold>) were not obtained. The nitrophenyl substituted analog <bold>3i</bold> was used for the next reaction without further purification due to inseparable impurities.</p>
<fig id="S1" position="float">
<label>Scheme 1</label>
<caption><p>Synthesis of <italic>N</italic>-pyranonyl propargylamines <bold>3a&#x02212;3k</bold>.</p></caption>
<graphic xlink:href="fchem-08-00772-g0002.tif"/>
</fig>
<p>With the cycloisomerization precursors <bold>3a</bold>&#x02013;<bold>3i</bold> in hand, the cycloisomerization conditions were examined using the simple <bold>3a</bold> as a model substrate (<xref ref-type="table" rid="T1">Table 1</xref>). Initially, cycloisomerization of <bold>3a</bold> was conducted under thermal rearrangement conditions. When <bold>3a</bold> was heated at 120&#x000B0;C in DMSO for 10 h, the desired 5-azaisocoumarin <bold>4a</bold> was obtained in poor yield (15%, <xref ref-type="table" rid="T1">Table 1</xref>, entry 1). The reaction was performed at higher temperature (220&#x000B0;C) in triethylene glycol (TEG) (Han, <xref ref-type="bibr" rid="B11">2017</xref>), affording 5-azaisocoumarin <bold>4a</bold> in a slightly higher yield (28%, entry 2). The structure of <bold>4a</bold> was confirmed by comparison of its NMR spectrum with previously reported data (<xref ref-type="supplementary-material" rid="SM1">Table S1</xref>) (Hellal et al., <xref ref-type="bibr" rid="B12">2008</xref>). Recently, many research groups have continuously reported the efficiency of various transition-metal Lewis acid catalysts for alkyne activation in cycloisomerization reaction (Abbiati et al., <xref ref-type="bibr" rid="B1">2003</xref>; Yan et al., <xref ref-type="bibr" rid="B36">2007</xref>; Cacchi et al., <xref ref-type="bibr" rid="B4">2008</xref>; Saito et al., <xref ref-type="bibr" rid="B31">2009</xref>; Jiang et al., <xref ref-type="bibr" rid="B13">2010</xref>; Fei et al., <xref ref-type="bibr" rid="B7">2011</xref>; Miku&#x00161;ek et al., <xref ref-type="bibr" rid="B21">2016</xref>; Vessally et al., <xref ref-type="bibr" rid="B34">2016</xref>; Nizami and Hua, <xref ref-type="bibr" rid="B23">2017</xref>; Sakthivel et al., <xref ref-type="bibr" rid="B32">2017</xref>; Gianni et al., <xref ref-type="bibr" rid="B10">2018</xref>; Lyubov&#x00027;N et al., <xref ref-type="bibr" rid="B17">2018</xref>; Mancuso et al., <xref ref-type="bibr" rid="B19">2018</xref>; Ahn et al., <xref ref-type="bibr" rid="B2">2019</xref>). To increase the product yield, cycloisomerization was performed in the presence of various metal catalysts, including Ag(I), Au(I), Cu(I), Cu(II), and In(III). Based on our previous work (Ahn et al., <xref ref-type="bibr" rid="B2">2019</xref>), the cycloisomerization of <bold>3a</bold> was performed with 0.2 equiv. of AgSbF<sub>6</sub> (entry 3), affording <bold>4a</bold> in a higher yield (38%) than that without the catalyst after heating in DMSO at 120&#x000B0;C for 7 h. Encouraged by this yield improvement with the Ag(I) catalyst, various counter-anions was screened (entries 4&#x02013;7) given that the alkyne-activating Lewis acidity of metal ions such as Ag(I) depends on the nature of the counter-anion (Yamamoto, <xref ref-type="bibr" rid="B35">2000</xref>; Lu et al., <xref ref-type="bibr" rid="B16">2017</xref>). When Ag<sub>2</sub>O was employed, the yield of <bold>4a</bold> did not notably improve over that obtained with AgSbF<sub>6</sub> (38%, entry 4). However, the yields increased slightly when AgCl (50%, entry 5) or AgNO<sub>3</sub> (53%, entry 6) were used. The best result was obtained when the cycloisomerization was performed with AgOTf, furnishing <bold>4a</bold> in 66% yield (entry 7). Moreover, the reaction proceeded to completion much faster (2 h) than with AgSbF<sub>6</sub>. Although regioisomeric byproducts were not isolated as expected, the optimal yield for the cycloisomerization of <italic>N</italic>-pyranonyl propargylamine precursors <bold>3a</bold> was slightly lower than that reported in a previous study on pyridocoumarins (Ahn et al., <xref ref-type="bibr" rid="B2">2019</xref>), likely because of the greater degree of decomposition of the acid-labile pyrone moiety. When the reaction was conducted with AuCl, the yield was reduced compared to that observed in the thermal aza-Claisen rearrangement in TEG (24%, entry 8). Furthermore, the desired cycloisomerization product <bold>4a</bold> was not obtained when using InCl<sub>3</sub> (entry 9). Cu(I) and Cu(II) catalysts afforded 5-azaisocoumarin <bold>4a</bold> in better yields than with Au(I) or In(III) catalysts (33%&#x02212;62%; entries 10&#x02013;14). Although CuI afforded <bold>4a</bold> in the best yield among the copper catalysts tested herein (62%, entry 11), the yield of <bold>4a</bold> and reaction rate did not show any notable improvements over that obtained with AgOTf. Other polar solvents including DMF (entry 15), MeCN (entry 16), and ionic liquid systems (entries 17&#x02013;18), resulted in lower reaction rates and yields of <bold>4a</bold>. In particular, the use of an ionic liquid hampered the cycloisomerization, contrary to previous reports (Corma et al., <xref ref-type="bibr" rid="B5">2005</xref>; Neatu et al., <xref ref-type="bibr" rid="B22">2009</xref>; Mancuso et al., <xref ref-type="bibr" rid="B18">2019</xref>). The lower yields obtained in ionic liquids was attributed to the inhibition of the interaction between the alkyne and metal catalyst by the highly polar solvent.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Investigation of reaction conditions for the cycloisomerization of <bold>3a</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" colspan="5" style="border-bottom: thin solid #000000;"><inline-graphic xlink:href="fchem-08-00772-i0001.tif"/></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Entry</bold></th>
<th valign="top" align="center"><bold>Catalyst</bold></th>
<th valign="top" align="center"><bold>Solvent</bold><xref ref-type="table-fn" rid="TN1"><sup><bold>a</bold></sup></xref></th>
<th valign="top" align="center"><bold>Time (h)</bold></th>
<th valign="top" align="center"><bold>Yield (%)</bold></th>
</tr>
</thead>
<tbody><tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">15</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">TEG<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">28</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">AgSbF<sub>6</sub></td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">38</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="center">Ag<sub>2</sub>O</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">38</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="center">AgCl</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">50</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="center">AgNO<sub>3</sub></td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">53</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="center">AgOTf</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">66</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="center">AuCl</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">24</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="center">InCl<sub>3</sub></td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">NR<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="center">Cu<sub>2</sub>O</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">61</td>
</tr>
<tr>
<td valign="top" align="left">11</td>
<td valign="top" align="center">CuI</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">62</td>
</tr>
<tr>
<td valign="top" align="left">12</td>
<td valign="top" align="center">CuCl</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">58</td>
</tr>
<tr>
<td valign="top" align="left">13</td>
<td valign="top" align="center">CuBr</td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">33</td>
</tr>
<tr>
<td valign="top" align="left">14</td>
<td valign="top" align="center">Cu(OAc)<sub>2</sub></td>
<td valign="top" align="center">DMSO</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">46</td>
</tr>
<tr>
<td valign="top" align="left">15</td>
<td valign="top" align="center">AgOTf</td>
<td valign="top" align="center">DMF</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">46</td>
</tr>
<tr>
<td valign="top" align="left">16</td>
<td valign="top" align="center">AgOTf</td>
<td valign="top" align="center">MeCN<xref ref-type="table-fn" rid="TN4"><sup>d</sup></xref></td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">52</td>
</tr>
<tr>
<td valign="top" align="left">17</td>
<td valign="top" align="center">AgOTf</td>
<td valign="top" align="center">DMSO/IL<xref ref-type="table-fn" rid="TN5"><sup>e</sup></xref></td>
<td valign="top" align="center">28</td>
<td valign="top" align="center">25</td>
</tr>
<tr>
<td valign="top" align="left">18</td>
<td valign="top" align="center">AgOTf</td>
<td valign="top" align="center">IL<xref ref-type="table-fn" rid="TN5"><sup>f</sup></xref></td>
<td valign="top" align="center">28</td>
<td valign="top" align="center">NRa<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>a</label>
<p><italic>0.06 M solution of <bold>3a</bold>;</italic></p></fn>
<fn id="TN2">
<label>b</label>
<p><italic>0.05 M solution of <bold>3a</bold> in triethylene glycol at 220&#x02013;230&#x000B0;C</italic>.</p></fn>
<fn id="TN3">
<label>c</label>
<p><italic>Starting material was recovered;</italic></p></fn>
<fn id="TN4">
<label>d</label>
<p><italic>reflux</italic>.</p></fn>
<fn id="TN5">
<label>e,f</label>
<p><italic>IL = Ionic liquid = [EMIm][EtSO<sub>4</sub>], DMSO: [EMIm][EtSO<sub>4</sub>] = 10: 1</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Next, the scope and limitations of the newly developed Ag(I)-catalyzed 3-aryl-5-azaisocoumarin synthesis were examined (<xref ref-type="table" rid="T2">Table 2</xref>). We attempted to synthesize the 3-aryl-5-azaisocoumarins from corresponding substituted alkynes (<bold>3b</bold>&#x02013;<bold>3i</bold>). Methyl (<bold>3b</bold>&#x02013;<bold>3c</bold>; entry 1&#x02013;2) and phenyl substituted (<bold>3d</bold>&#x02013;<bold>3f</bold>; entry 3&#x02013;5) propargylamines generated the corresponding 3-aryl-5-azaisocoumarins (<bold>4b</bold>&#x02013;<bold>4f</bold>) without any notable yield decreases. However, cycloisomerization under standard condition of enynylamine precursors (<bold>3g</bold>&#x02013;<bold>3h</bold>; entry 6&#x02013;7) resulted in an unidentifiable mixture of byproducts, whereas only substrates were recovered when the reactions were conducted at ambient temperature. These results were attributed to preference of the metal-alkyne complex for reaction with the electron-rich alkene rather than enolizable &#x003B1;-position. Although the cycloisomerization reaction of triisopropylsilyl (TIPS) propargylamine (<bold>3i</bold>) was allowed to proceed for 24 h, only substrate <bold>3i</bold> was recovered in 88% yield (entry 8). This implied that the bulky silyl substituents of alkyne can interfere with formation of the metal-alkyne complex.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Substrate scope of the AgOTf-catalyzed cycloisomerization toward 3-aryl-5-azaisocoumarin.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr style="border-bottom: thin solid #000000;">
<th valign="top" align="left" colspan="5"><inline-graphic xlink:href="fchem-08-00772-i0002.tif"/></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Entry</bold></th>
<th valign="top" align="left"><bold>Substrate</bold></th>
<th valign="top" align="center"><bold>Product</bold></th>
<th valign="top" align="center"><bold>Time (h)</bold></th>
<th valign="top" align="center"><bold>Yield (%)</bold></th>
</tr>
</thead>
<tbody><tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">1</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0003.tif"/></td>
<td valign="middle" align="center"><inline-graphic xlink:href="fchem-08-00772-i0004.tif"/></td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">65</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">2</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0005.tif"/></td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0006.tif"/></td>
<td valign="middle" align="center">3</td>
<td valign="middle" align="center">54</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">3</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0007.tif"/></td>
<td valign="middle" align="center"><inline-graphic xlink:href="fchem-08-00772-i0008.tif"/></td>
<td valign="middle" align="center">3</td>
<td valign="middle" align="center">60</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">4</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0009.tif"/></td>
<td valign="middle" align="center"><inline-graphic xlink:href="fchem-08-00772-i0010.tif"/></td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">48</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">5</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0011.tif"/></td>
<td valign="middle" align="center"><inline-graphic xlink:href="fchem-08-00772-i0012.tif"/></td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">52<xref ref-type="table-fn" rid="TN6"><sup>a</sup></xref></td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">6</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0013.tif"/></td>
<td valign="middle" align="center">&#x02013;</td>
<td valign="middle" align="center">3</td>
<td valign="middle" align="center">Decomposed</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">7</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0014.tif"/></td>
<td valign="middle" align="center">&#x02013;</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">Decomposed</td>
</tr> <tr style="border-bottom: thin solid #000000;">
<td valign="middle" align="left">8</td>
<td valign="middle" align="left"><inline-graphic xlink:href="fchem-08-00772-i0015.tif"/></td>
<td valign="middle" align="center">&#x02013;</td>
<td valign="middle" align="center">6</td>
<td valign="middle" align="center">NR<xref ref-type="table-fn" rid="TN7"><sup>b</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN6">
<label>a</label>
<p><italic>Two steps yield from <bold>2</bold>;</italic></p></fn>
<fn id="TN7">
 <label>b</label>
<p><italic>Starting material was recovered</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec sec-type="conclusions" id="s4">
<title>Conclusion</title>
<p>In conclusion, an alternative synthetic route for 3-aryl-5-azaisocoumarins was developed which includes novel approach to install pyridine moieties on a readily available phenyl-2-pyrone precursor via regioselective metal-catalyzed cycloisomerization. Through an intensive preliminary investigation, AgOTf was determined to be an adequate alkyne-activation catalyst and was applicable in rearrangement of <italic>N</italic>-pyranonyl propargylamines bearing methyl or phenyl substituents to C-6 or C-8 substituted 3-aryl-5-azaisocoumarin. Derivatization of the pyridine moiety was accomplished efficiently via three-step reaction using the common starting material hydroxy-2-pyrone <bold>1</bold> and known propargylamines. Considering that 3-phenyl-5-azaisocoumarin <bold>4a</bold>, which was synthesized previously as a regioisomeric mixture using conventional lactonization strategies, was obtained regioselectively in moderate yield, this novel step-economical procedure can be widely utilized in derivatization of C-3, C-6, and C-8 of 5-azaisocoumarins. Further studies on the synthetic applications of the newly developed method are currently underway.</p></sec>
<sec sec-type="data-availability-statement" id="s5">
<title>Data Availability Statement</title>
<p>All datasets generated for this study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary Material</xref>.</p></sec>
<sec id="s6">
<title>Author Contributions</title>
<p>YH conceptualized the work. JY and CL synthesized all compound and performed m.p. R<sub>f</sub>, NMR, IR, LRMS, and HRMS analysis. The manuscript was written by CL and YH. All authors approved the manuscript in its final form for publication.</p></sec>
<sec id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</body>
<back><sec sec-type="supplementary-material" id="s8">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2020.00772/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2020.00772/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbiati</surname> <given-names>G.</given-names></name> <name><surname>Arcadi</surname> <given-names>A.</given-names></name> <name><surname>Bianchi</surname> <given-names>G.</given-names></name> <name><surname>Di Giuseppe</surname> <given-names>S.</given-names></name> <name><surname>Marinelli</surname> <given-names>F.</given-names></name> <name><surname>Rossi</surname> <given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: A new one-pot approach to functionalized pyridines</article-title>. <source>J. Org. Chem.</source> <volume>68</volume>, <fpage>6959</fpage>&#x02013;<lpage>6966</lpage>. <pub-id pub-id-type="doi">10.1021/jo0347260</pub-id><pub-id pub-id-type="pmid">12946136</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname> <given-names>S.</given-names></name> <name><surname>Yoon</surname> <given-names>J. A.</given-names></name> <name><surname>Han</surname> <given-names>Y. T.</given-names></name></person-group> (<year>2019</year>). <article-title>Total synthesis of the natural pyridocoumarins goniothaline A and B</article-title>. <source>Synthesis</source> <volume>51</volume>, <fpage>552</fpage>&#x02013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1055/s-0037-1610909</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Begouin</surname> <given-names>A.</given-names></name> <name><surname>Maria-Jo&#x000E3;o</surname></name> <name><surname>Queiroz</surname> <given-names>R. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Tandem palladium/charcoal-copper(I) iodide (Pd/C-CuI) catalyzed Sonogashira coupling and intramolecular cyclization from 2-bromonicotinic acid (=2-bromopyridine-3-carboxylic acid) and ethynylarenes to 4-zzaphthalides (=furo[3,4-<italic>b</italic>]pyridin-5(7<italic>H</italic>)-ones) and 5-azaisocoumarins (=5<italic>H</italic>-pyrano[4, 3-<italic>b</italic>]pyridin-5-ones)</article-title>. <source>Helv. Chim. Acta</source> <volume>94</volume>, <fpage>1792</fpage>&#x02013;<lpage>1801</lpage>. <pub-id pub-id-type="doi">10.1002/hlca.201100060</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cacchi</surname> <given-names>S.</given-names></name> <name><surname>Fabrizi</surname> <given-names>G.</given-names></name> <name><surname>Filisti</surname> <given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>N</italic>-propargylic &#x003B2;-enaminones: Common intermediates for the synthesis of polysubstituted pyrroles and pyridines</article-title>. <source>Org. Lett.</source> <volume>10</volume>, <fpage>2629</fpage>&#x02013;<lpage>2632</lpage>. <pub-id pub-id-type="doi">10.1021/ol800518j</pub-id><pub-id pub-id-type="pmid">18507386</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corma</surname> <given-names>A.</given-names></name> <name><surname>Garc&#x000ED;a</surname> <given-names>H.</given-names></name> <name><surname>Leyva</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Palladium catalyzed cycloisomerization of 2,2-diallylmalonates in imidazolium ionic liquids</article-title>. <source>J. Organomet. Chem.</source> <volume>690</volume>, <fpage>3529</fpage>&#x02013;<lpage>3534</lpage>. <pub-id pub-id-type="doi">10.1016/j.jorganchem.2005.02.044</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>Y.</given-names></name> <name><surname>Nakagawa-Goto</surname> <given-names>K.</given-names></name> <name><surname>Lai</surname> <given-names>C.-Y.</given-names></name> <name><surname>Morris-Natschke</surname> <given-names>S. L.</given-names></name> <name><surname>Bastow</surname> <given-names>K. F.</given-names></name> <name><surname>Lee</surname> <given-names>K.-H.</given-names></name></person-group> (<year>2011</year>). <article-title>Antitumor agents 287. Substituted 4-amino-2<italic>H</italic>-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>21</volume>, <fpage>2341</fpage>&#x02013;<lpage>2344</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.02.084</pub-id><pub-id pub-id-type="pmid">21420855</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname> <given-names>N.</given-names></name> <name><surname>Yin</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Yao</surname> <given-names>Z.-J.</given-names></name></person-group> (<year>2011</year>). <article-title>CuCl<sub>2</sub>-promoted 6-<italic>endo</italic>-dig chlorocyclization and oxidative aromatization cascade: Efficient construction of 1-azaanthraquinones from <italic>N</italic>-propargylaminoquinones</article-title>. <source>Org. Lett.</source> <volume>13</volume>, <fpage>4208</fpage>&#x02013;<lpage>4211</lpage>. <pub-id pub-id-type="doi">10.1021/ol201542h</pub-id><pub-id pub-id-type="pmid">21766780</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Foye</surname> <given-names>W. O.</given-names></name></person-group> (<year>2008</year>). <source>Foye&#x00027;s Principles of Medicinal Chemistry</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name>.</citation></ref>
<ref id="B9">
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Gaikwad</surname> <given-names>P. L.</given-names></name> <name><surname>Gandhi</surname> <given-names>P. S.</given-names></name> <name><surname>Jagdale</surname> <given-names>D. M.</given-names></name> <name><surname>Kadam</surname> <given-names>V. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The use of bioisosterism in drug design and molecular modification</article-title>. <source>Am. J. Pharmtech Res.</source> <volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>23</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://ajptr.com/assets/upload/publish_article/AJPTR%20article%20Priyanka%20Gaikwad_9133.pdf">http://ajptr.com/assets/upload/publish_article/AJPTR%20article%20Priyanka%20Gaikwad_9133.pdf</ext-link></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gianni</surname> <given-names>J.</given-names></name> <name><surname>Pirovano</surname> <given-names>V.</given-names></name> <name><surname>Abbiati</surname> <given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Silver triflate/<italic>p</italic>-TSA co-catalysed synthesis of 3-substituted isocoumarins from 2-alkynylbenzoates</article-title>. <source>Org. Biomol. Chem.</source> <volume>16</volume>, <fpage>3213</fpage>&#x02013;<lpage>3219</lpage>. <pub-id pub-id-type="doi">10.1039/c8ob00436f</pub-id><pub-id pub-id-type="pmid">29658032</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Synthesis of proposed structure of rennellianone B: A study on rearrangement of anthraquinonyl propargyl ether toward 2<italic>H</italic>-pyranoanthraquinone</article-title>. <source>Tetrahedron Lett.</source> <volume>58</volume>, <fpage>556</fpage>&#x02013;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2016.12.080</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hellal</surname> <given-names>M.</given-names></name> <name><surname>Bourguignon</surname> <given-names>J.-J.</given-names></name> <name><surname>Bihel</surname> <given-names>F. J.-J.</given-names></name></person-group> (<year>2008</year>). <article-title>6-<italic>endo</italic>-dig cyclization of heteroarylesters to alkynes promoted by Lewis acid catalyst in the presence of Br&#x000F8;nsted acid</article-title>. <source>Tetrahedron Lett.</source> <volume>49</volume>, <fpage>62</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2007.11.020</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>C.</given-names></name> <name><surname>Xu</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Yao</surname> <given-names>Z.-J.</given-names></name></person-group> (<year>2010</year>). <article-title>Azaanthraquinone assembly from <italic>N</italic>-propargylamino quinone via a Au(I)-catalyzed 6-<italic>endo</italic>-dig cycloisomerization</article-title>. <source>J. Org. Chem.</source> <volume>75</volume>, <fpage>4323</fpage>&#x02013;<lpage>4325</lpage>. <pub-id pub-id-type="doi">10.1021/jo1006637</pub-id><pub-id pub-id-type="pmid">20491491</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>E.</given-names></name> <name><surname>Lim</surname> <given-names>S.-M.</given-names></name> <name><surname>Kim</surname> <given-names>M.-S.</given-names></name> <name><surname>Yoo</surname> <given-names>S.-H.</given-names></name> <name><surname>Kim</surname> <given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Phyllodulcin, a natural sweetener, regulates obesity-related metabolic changes and fat browning-related genes of subcutaneous white adipose tissue in high-fat diet-induced obese mice</article-title>. <source>Nutrients</source> <volume>9</volume>:<fpage>1049</fpage>. <pub-id pub-id-type="doi">10.3390/nu9101049</pub-id><pub-id pub-id-type="pmid">28934139</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Chin</surname> <given-names>E.</given-names></name> <name><surname>Lui</surname> <given-names>A. S.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>One-pot synthesis of phthalides via regioselective intramolecular cyclization from <italic>ortho</italic>-alkynylbenzaldehydes</article-title>. <source>Tetrahedron Lett.</source> <volume>51</volume>, <fpage>5937</fpage>&#x02013;<lpage>5939</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2010.09.023</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>Z.</given-names></name> <name><surname>Han</surname> <given-names>J.</given-names></name> <name><surname>Okoromoba</surname> <given-names>O. E.</given-names></name> <name><surname>Shimizu</surname> <given-names>N.</given-names></name> <name><surname>Amii</surname> <given-names>H.</given-names></name> <name><surname>Tormena</surname> <given-names>C. F.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Predicting couterion effects using a gold affinity index and a hydrogen bonding basicity index</article-title>. <source>Org. Lett</source>. <volume>19</volume>, <fpage>5848</fpage>&#x02013;<lpage>5851</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.7b02829</pub-id><pub-id pub-id-type="pmid">29058906</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyubov&#x00027;N</surname> <given-names>S</given-names></name> <name><surname>Sagitova</surname> <given-names>E. F.</given-names></name> <name><surname>Markova</surname> <given-names>M. V.</given-names></name> <name><surname>Igor,&#x00027;A</surname> <given-names>U.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Acylethynylpyrroles as a platform for the one-pot access to 2-(pyrrol-2-yl)-3-acylpyridines via the dihydrogenative annelation with propargylamine</article-title>. <source>Tetrahedron Lett.</source> <volume>59</volume>, <fpage>4047</fpage>&#x02013;<lpage>4049</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2018.09.066</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname> <given-names>R.</given-names></name> <name><surname>Mili,&#x000E8;</surname> <given-names>R.</given-names></name> <name><surname>Palumbo Piccionello</surname> <given-names>A.</given-names></name> <name><surname>Olivieri</surname> <given-names>D.</given-names></name> <name><surname>Della Ca,&#x00027;</surname> <given-names>N.</given-names></name> <name><surname>Carfagna</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Catalytic carbonylative double cyclization of 2-(3-hydroxy-1-yn-1-yl) phenols in ionic liquid leading to furobenzofuranone derivatives</article-title>. <source>J. Org. Chem.</source> <volume>84</volume>, <fpage>7303</fpage>&#x02013;<lpage>7311</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.9b00952</pub-id><pub-id pub-id-type="pmid">31117578</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname> <given-names>R.</given-names></name> <name><surname>Pomelli</surname> <given-names>C. S.</given-names></name> <name><surname>Chiappetta</surname> <given-names>P.</given-names></name> <name><surname>Gioia</surname> <given-names>K. F.</given-names></name> <name><surname>Maner</surname> <given-names>A.</given-names></name> <name><surname>Marino</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Divergent syntheses of (<italic>Z</italic>)-3-alkylideneisobenzofuran-1 (3<italic>H</italic>)-ones and 1<italic>H</italic>-isochromen-1-ones by copper-catalyzed cycloisomerization of 2-alkynylbenzoic acids in ionic liquids</article-title>. <source>J. Org. Chem.</source> <volume>83</volume>, <fpage>6673</fpage>&#x02013;<lpage>6680</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.8b00923</pub-id><pub-id pub-id-type="pmid">29792429</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>H.</given-names></name> <name><surname>Shimoda</surname> <given-names>H.</given-names></name> <name><surname>Yamahara</surname> <given-names>J.</given-names></name> <name><surname>Yoshikawa</surname> <given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Immunomodulatory activity of thunberginol a and related compounds isolated from Hydrangeae Dulcis Folium on splenocyte proliferation activated by mitogens</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>8</volume>, <fpage>215</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-894x(97)10221-9</pub-id><pub-id pub-id-type="pmid">9871657</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miku&#x00161;ek</surname> <given-names>J.</given-names></name> <name><surname>Matou&#x00161;</surname> <given-names>P.</given-names></name> <name><surname>Matou&#x00161;ov&#x000E1;</surname> <given-names>E.</given-names></name> <name><surname>Janou&#x00161;ek</surname> <given-names>M.</given-names></name> <name><surname>Kune&#x00161;</surname> <given-names>J.</given-names></name> <name><surname>Pour</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Substrate control in the gold (I)-catalyzed cyclization of &#x003B2;-propargylamino acrylic esters and further transformations of the resultant dihydropyridines</article-title>. <source>Adv. Synth. Catal.</source> <volume>358</volume>, <fpage>2912</fpage>&#x02013;<lpage>2922</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201600412</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neatu</surname> <given-names>F.</given-names></name> <name><surname>P&#x000E2;rvulescu</surname> <given-names>V. I.</given-names></name> <name><surname>Michelet</surname> <given-names>V.</given-names></name> <name><surname>G&#x000EA;net</surname> <given-names>J.-P.</given-names></name> <name><surname>Goguet</surname> <given-names>A.</given-names></name> <name><surname>Hardacre</surname> <given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Gold imidazolium-based ionic liquids, efficient catalysts for cycloisomerization of &#x003B3;-acetylenic carboxylic acids</article-title>. <source>New J. Chem.</source> <volume>33</volume>, <fpage>102</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1039/B812580E</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nizami</surname> <given-names>T. A.</given-names></name> <name><surname>Hua</surname> <given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Silver-catalyzed chemoselective annulation of propargyl amines with alkynes for access to pyridines and pyrroles</article-title>. <source>Tetrahedron</source> <volume>73</volume>, <fpage>6080</fpage>&#x02013;<lpage>6084</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2017.09.002</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname> <given-names>S.</given-names></name> <name><surname>Chatare</surname> <given-names>V.</given-names></name> <name><surname>Pal</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Isocoumarin and its derivatives: An overview on their synthesis and applications</article-title>. <source>Curr. Org. Chem.</source> <volume>15</volume>, <fpage>782</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.2174/138527211794518970</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname> <given-names>B.</given-names></name> <name><surname>Bhadra</surname> <given-names>J.</given-names></name> <name><surname>Sarkar</surname> <given-names>T. K.</given-names></name></person-group> (<year>2011</year>). <article-title>An approach to highly functionalized quinolines and isoquinolines via a gold-catalyzed benzannulation</article-title>. <source>Synlett</source> <volume>5</volume>, <fpage>689</fpage>&#x02013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1055/s-0030-1259555</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>J. H.</given-names></name> <name><surname>Bhilare</surname> <given-names>S. V.</given-names></name> <name><surname>Youn</surname> <given-names>S. W.</given-names></name></person-group> (<year>2011</year>). <article-title>NHC-catalyzed oxidative cyclization reactions of 2-alkynylbenzaldehydes under aerobic conditions: Synthesis of O-heterocycles</article-title>. <source>Org. Lett.</source> <volume>13</volume>, <fpage>2228</fpage>&#x02013;<lpage>2231</lpage>. <pub-id pub-id-type="doi">10.1021/ol200481u</pub-id><pub-id pub-id-type="pmid">21446687</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname> <given-names>J. V.</given-names></name> <name><surname>Para</surname> <given-names>K. S.</given-names></name> <name><surname>Tummino</surname> <given-names>P. J.</given-names></name> <name><surname>Ferguson</surname> <given-names>D.</given-names></name> <name><surname>McQuade</surname> <given-names>T. J.</given-names></name> <name><surname>Lumney</surname> <given-names>E. A.</given-names></name> <etal/></person-group>. (<year>1995</year>). <article-title>Nonpeptidic potent HIV-1 protease inhibitors:(4-hydroxy-6-phenyl-2-oxo-2<italic>H</italic>-pyran-3-yl) thiomethanes that span P<sub>1</sub>-P<sub>2</sub>&#x00027; subsites in a unique mode of binding</article-title>. <source>J. Med. Chem.</source> <volume>38</volume>, <fpage>898</fpage>&#x02013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1021/jm00006a007</pub-id><pub-id pub-id-type="pmid">7699705</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saddiqa</surname> <given-names>A.</given-names></name> <name><surname>&#x000C7;akmak</surname> <given-names>O.</given-names></name> <name><surname>Usman</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Isocoumarins and 3, 4-dihydroisocoumarins, amazing natural products: A review</article-title>. <source>Turk. J. Chem.</source> <volume>41</volume>, <fpage>153</fpage>&#x02013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.3906/kim-1604-66</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname> <given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Synthesis of montroumarin</article-title>. <source>Z. Naturforsch.</source> <volume>58</volume>, <fpage>691</fpage>&#x02013;<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2003-9-1017</pub-id><pub-id pub-id-type="pmid">14577633</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Isocoumarins, miraculous natural products blessed with diverse pharmacological activities</article-title>. <source>Eur. J. Med. Chem.</source> <volume>116</volume>, <fpage>290</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.03.025</pub-id><pub-id pub-id-type="pmid">27155563</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname> <given-names>A.</given-names></name> <name><surname>Konishi</surname> <given-names>T.</given-names></name> <name><surname>Hanzawa</surname> <given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Synthesis of pyrroles by gold(I)-catalyzed amino-Claisen rearrangement of <italic>N</italic>-propargyl enaminone derivatives</article-title>. <source>Org. Lett.</source> <volume>11</volume>, <fpage>372</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1021/ol902716n</pub-id><pub-id pub-id-type="pmid">20025257</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakthivel</surname> <given-names>S.</given-names></name> <name><surname>Sharma</surname> <given-names>A.</given-names></name> <name><surname>Balamurugan</surname> <given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Silver-catalyzed synthesis of substituted pyridine derivatives from <italic>N</italic>-propargylic &#x003B1;-enamino esters</article-title>. <source>Eur. J. Org. Chem</source>. <fpage>3941</fpage>&#x02013;<lpage>3946</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201700559</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>J. B.</given-names></name> <name><surname>Mishra</surname> <given-names>K.</given-names></name> <name><surname>Gupta</surname> <given-names>T.</given-names></name> <name><surname>Singh</surname> <given-names>R. M.</given-names></name></person-group> (<year>2018</year>). <article-title>TBHP-promoted oxidative cyclization of <italic>o</italic>-alkynylquinoline aldehydes: Metal/additive-free domino synthesis of pyrano [4,3-<italic>b</italic>] quinolin-1-ones</article-title>. <source>Tetrahedron Lett.</source> <volume>59</volume>, <fpage>1019</fpage>&#x02013;<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2018.01.083</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vessally</surname> <given-names>E.</given-names></name> <name><surname>Hosseinian</surname> <given-names>A.</given-names></name> <name><surname>Edjlali</surname> <given-names>L.</given-names></name> <name><surname>Bekhradnia</surname> <given-names>A.</given-names></name> <name><surname>Esrafili</surname> <given-names>M. D.</given-names></name></person-group> (<year>2016</year>). <article-title>New page to access pyridine derivatives: Synthesis from <italic>N</italic>-propargylamines</article-title>. <source>RSC Adv.</source> <volume>6</volume>, <fpage>71662</fpage>&#x02013;<lpage>71675</lpage>. <pub-id pub-id-type="doi">10.1039/C6RA08720E</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>H.</given-names></name></person-group> (<year>2000</year>). <source>Lewis Acids in Organic Synthesis</source>. <publisher-loc>Weinheim</publisher-loc>: <publisher-name>Wiley-VCH Verlag GmbH</publisher-name>.</citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>J.-Z.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Rao</surname> <given-names>G.-W.</given-names></name></person-group> (<year>2007</year>). <article-title>One-pot synthesis of new A-ring fused steroidal pyridines</article-title>. <source>Steroids</source> <volume>72</volume>, <fpage>736</fpage>&#x02013;<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2007.06.002</pub-id><pub-id pub-id-type="pmid">17686502</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>J. A.</given-names></name> <name><surname>Han</surname> <given-names>Y. T.</given-names></name></person-group> (<year>2019</year>). <article-title>Efficient synthesis of pyrido[3,2-c]coumarins via silver nitrate catalyzed cycloisomerization and application to the first synthesis of polyneomarline C</article-title>. <source>Synthesis</source> <volume>51</volume>, <fpage>4611</fpage>&#x02013;<lpage>4618</lpage>. <pub-id pub-id-type="doi">10.1055/s-0037-1610730</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname> <given-names>M.</given-names></name> <name><surname>Harada</surname> <given-names>E.</given-names></name> <name><surname>Naitoh</surname> <given-names>Y.</given-names></name> <name><surname>Inoue</surname> <given-names>K.</given-names></name> <name><surname>Matsuda</surname> <given-names>H.</given-names></name> <name><surname>Shimoda</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>1994</year>). <article-title>Development of bioactive functions in Hydrangeae Dulcis Folium. III. On the antiallergic and antimicrobial principles of Hydrangeae Dulcis Folium. (1). Thunberginols A, B, and F</article-title>. <source>Chem. Pharm. Bull.</source> <volume>42</volume>, <fpage>2225</fpage>&#x02013;<lpage>2230</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.42.2225</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname> <given-names>M.</given-names></name> <name><surname>Matsuda</surname> <given-names>H.</given-names></name> <name><surname>Shimoda</surname> <given-names>H.</given-names></name> <name><surname>Shimada</surname> <given-names>H.</given-names></name> <name><surname>Harada</surname> <given-names>E.</given-names></name> <name><surname>Naitoh</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>1996</year>). <article-title>Development of bioactive functions in Hydrangeae Dulcis Folium. V. On the antiallergic and antimicrobial principles of hydrangeae dulcis folium. (2). Thunberginols C, D, and E, thunberginol G 3&#x00027;-<italic>O</italic>-glucoside, (-)-hydrangenol 4&#x00027;-<italic>O</italic>-glucoside, and (&#x0002B;)-hydrangenol 4&#x00027;-<italic>O</italic>-glucoside</article-title>. <source>Chem. Pharm. Bull.</source> <volume>44</volume>, <fpage>1440</fpage>&#x02013;<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.44.1440</pub-id><pub-id pub-id-type="pmid">8795265</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname> <given-names>M.</given-names></name> <name><surname>Uchida</surname> <given-names>E.</given-names></name> <name><surname>Chatani</surname> <given-names>N.</given-names></name> <name><surname>Murakami</surname> <given-names>N.</given-names></name> <name><surname>Yamahara</surname> <given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>Thunberginols A, B, and F, new antiallergic and antimicrobial principles from Hydrangeae Dulcis Folium</article-title>. <source>Chem. Pharm. Bull.</source> <volume>40</volume>, <fpage>3121</fpage>&#x02013;<lpage>3123</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.40.3121</pub-id><pub-id pub-id-type="pmid">1477932</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This research was funded by the National Research Foundation of Korea, NRF-2020R1F1A1058295.</p>
</fn>
</fn-group>
</back>
</article>